BWS Financial Maintains Bullish Bias on SciClone Pharmaceuticals (SCLN)
Tweet Send to a Friend
BWS Financial continues a 'Buy' rating and $7.25 price target on SciClone Pharmaceuticals (Nasdaq: SCLN).
A BWS ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
A BWS ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
